• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Re: Michael Baboudjian, Romain Diamand, Alessandro Uleri, et al. Does Overgrading on Targeted Biopsy of Magnetic Resonance Imaging-visible Lesions in Prostate Cancer Lead to Overtreatment? Eur Urol. In press. https://doi.org/10.1016/j.eururo.2024.02.003.

作者信息

Vickers Andrew J

机构信息

Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

出版信息

Eur Urol. 2024 Sep;86(3):e71. doi: 10.1016/j.eururo.2024.05.015. Epub 2024 May 25.

DOI:10.1016/j.eururo.2024.05.015
PMID:38797599
Abstract
摘要

相似文献

1
Re: Michael Baboudjian, Romain Diamand, Alessandro Uleri, et al. Does Overgrading on Targeted Biopsy of Magnetic Resonance Imaging-visible Lesions in Prostate Cancer Lead to Overtreatment? Eur Urol. In press. https://doi.org/10.1016/j.eururo.2024.02.003.回复：迈克尔·巴博吉安、罗曼·迪亚曼德、亚历山德罗·乌莱里等人。前列腺癌磁共振成像可见病灶靶向活检中的过度分级会导致过度治疗吗？《欧洲泌尿外科杂志》。即将发表。https://doi.org/10.1016/j.eururo.2024.02.003 。
Eur Urol. 2024 Sep;86(3):e71. doi: 10.1016/j.eururo.2024.05.015. Epub 2024 May 25.
2
Re: Michael Baboudjian, Romain Diamand, Alessandro Uleri, et al. Does Overgrading on Targeted Biopsy of Magnetic Resonance Imaging-visible Lesions in Prostate Cancer Lead to Overtreatment? Eur Urol. In press. https://doi.org/10.1016/j.eururo.2024.02.003.回复：迈克尔·巴博德贾恩、罗曼·迪亚曼德、亚历山德罗·乌莱里等人。前列腺癌磁共振成像可见病灶靶向活检的过度分级会导致过度治疗吗？《欧洲泌尿外科杂志》。即将发表。https://doi.org/10.1016/j.eururo.2024.02.003 。
Eur Urol. 2024 Sep;86(3):e64-e65. doi: 10.1016/j.eururo.2024.04.033. Epub 2024 May 14.
3
Reply to Andrew J. Vickers' Letter to the Editor re: Michael Baboudjian, Romain Diamand, Alessandro Uleri, et al. Does Overgrading on Targeted Biopsy of Magnetic Resonance Imaging-visible Lesions in Prostate Cancer Lead to Overtreatment? Eur Urol. In press. https://doi.org/10.1016/j.eururo.2024.02.003.回复安德鲁·J·维克斯致编辑的信，主题为：迈克尔·巴布吉安、罗曼·迪亚曼德、亚历山德罗·乌莱里等人。前列腺癌磁共振成像可见病灶靶向活检的过度分级会导致过度治疗吗？《欧洲泌尿外科杂志》。即将发表。https://doi.org/10.1016/j.eururo.2024.02.003 。
Eur Urol. 2024 Sep;86(3):e72. doi: 10.1016/j.eururo.2024.05.016. Epub 2024 May 24.
4
Reply to Hein V. Stroomberg, Klaus Brasso, and Andreas Røder's Letter to the Editor re: Michael Baboudjian, Romain Diamand, Alessandro Uleri, et al. Does Overgrading on Targeted Biopsy of Magnetic Resonance Imaging-visible Lesions in Prostate Cancer Lead to Overtreatment? Eur Urol. In press. https://doi.org/10.1016/j.eururo.2024.02.003.回复海因·V·斯特鲁姆伯格、克劳斯·布拉索和安德烈亚斯·勒德致编辑的信，内容关于：迈克尔·巴博吉安、罗曼·迪亚曼德、亚历山德罗·乌莱里等人。前列腺癌磁共振成像可见病灶靶向活检的过度分级会导致过度治疗吗？《欧洲泌尿外科杂志》。即将发表。https://doi.org/10.1016/j.eururo.2024.02.003 。
Eur Urol. 2024 Sep;86(3):e66. doi: 10.1016/j.eururo.2024.05.017. Epub 2024 May 24.
5
Does Overgrading on Targeted Biopsy of Magnetic Resonance Imaging-visible Lesions in Prostate Cancer Lead to Overtreatment?前列腺癌中磁共振成像可见病变的靶向活检过度分级是否导致过度治疗？
Eur Urol. 2024 Sep;86(3):232-237. doi: 10.1016/j.eururo.2024.02.003. Epub 2024 Mar 16.
6
Re: Michael S. Leapman, Cassandra L. Thiel, Ilyssa O. Gordon, et al. Environmental Impact of Prostate Magnetic Resonance Imaging and Transrectal Ultrasound Guided Prostate Biopsy. Eur Urol. 2023;83:463-71.
Eur Urol. 2023 Jul;84(1):e12. doi: 10.1016/j.eururo.2023.03.026. Epub 2023 Apr 6.
7
Re: Valentin H. Meissner, Isabel Rauscher, Kristina Schwamborn, et al. Radical Prostatectomy Without Prior Biopsy Following Multiparametric Magnetic Resonance Imaging and Prostate-specific Membrane Antigen Positron Emission Tomography. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.11.019.
Eur Urol. 2022 Jul;82(1):e15-e16. doi: 10.1016/j.eururo.2022.03.032. Epub 2022 Apr 12.
8
Re: Valentin H. Meissner, Isabel Rauscher, Kristina Schwamborn, et al. Radical Prostatectomy Without Prior Biopsy Following Multiparametric Magnetic Resonance Imaging and Prostate-specific Membrane Antigen Positron Emission Tomography. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.11.019.
Eur Urol. 2022 May;81(5):e121. doi: 10.1016/j.eururo.2021.12.042. Epub 2022 Feb 4.
9
Re: Valentin H. Meissner, Isabel Rauscher, Kristina Schwamborn, et al. Radical Prostatectomy Without Prior Biopsy Following Multiparametric Magnetic Resonance Imaging and Prostate-specific Membrane Antigen Positron Emission Tomography. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.11.019: A Storm in a Teacup.
Eur Urol. 2022 May;81(5):e115-e116. doi: 10.1016/j.eururo.2021.12.041. Epub 2022 Feb 9.
10
Re: George J. Netto, Mahul B. Amin, Eva M. Compérat, et al. Prostate Adenocarcinoma Grade Group 1: Rationale for Retaining a Cancer Label in the 2022 World Health Organization Classification. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2022.09.015.回复：乔治·J·内托、马胡尔·B·阿明、伊娃·M·孔佩拉特等人。前列腺腺癌1级组：在2022年世界卫生组织分类中保留癌症标签的理由。《欧洲泌尿外科杂志》。即将发表。https://doi.org/10.1016/j.eururo.2022.09.015
Eur Urol. 2023 Mar;83(3):e84-e86. doi: 10.1016/j.eururo.2022.11.024. Epub 2022 Dec 12.